

Discussion summary
Discussions highlight the importance of observational evidence and define RCTs, with some arguing observational data can be more ethical in medicine.
What the discussion says
- Observational evidence is valuable and sometimes preferable to RCTs.
- Some commenters emphasize the need for clear definitions of RCT.
- Debate exists over the ethics of RCTs versus observational studies in medicine.
“Definitions are the very basics in writing, check them before you publish.”
“In medicine, observational evidence is actually better and far more ethical than the RCT.”
Comments
Hacker News
by doginasuit
by SomeHacker44
I noticed that as well. My eyes feverishly scanning the previous paragraph for the definition.
by Vohlenzer
This is not happening.
> I was surprised to find that they usually discard papers based on observational evidence wholesale.
He he...welcome to the real world!
by qsera
by 1970-01-01
by KempyKolibri
by pinko
Don't forget that RCTs are very far from perfect and issues -- sometimes literally fatal issues -- have later turned up via observational evidence in large cohorts. Vioxx, for instance. Many others.
I believe, without the tiniest shred of doubt, that the only trials drugs need to go through are initial safety/toxicity trials (phases 0/1) and that everything else would be much better left to access+observation.
by A_D_E_P_T
I wish people would stop saying this. First, controls aren't necessarily "fake treatment", they are often compared to other standard treatments.
Second, the treatment being tested can actually harm the patient more, therefore the people receiving your alleged "fake treatment" can actually come out better off. Which is the "fake treatment" now?
I don't disagree with your final point, but mainly with this increasingly pervasive and wrong framing of RCTs.
by naasking
This is just nonsense. First, everyone in a trial is informed of the situation. It's not "unethical" unless you lie about it. If you participate in a trial, you do so knowing that you might not get the experimental drug. It's a selfless, honorable thing to do, and we shouldn't be framing it as some kind of scam.
Second, we don't give terminally ill people "fake treatment" (placebo trials). We give them current standard of care. Giving someone a placebo trial doesn't prove anything that would change clinical practice, because you want to know if the drug works better than what is out there today. Rarely is that standard of care "nothing", and this (bad controls) is actually a primary reason that a lot of drug company trials are rejected by the FDA.
If I didn't see the Wall Street Journal editorial board repeating the same garbage in defense of patent medicines, I'd write you off as simply having a sophomoric understanding of how trials work. I'm convinced that someone is driving this absurd narrative.
by timr
Should we demand an RCT before we accept evidence? Of course not. At some point you do have to make a choice on things.
And it should be noted that most drugs do have early cutoff criteria if the evidence is strong enough that it is working. It isn't like people are wanting to withhold good treatments from the world. Adding controls and randomizing them, though, has proven to be highly effective at helping progress.
by taeric
by samuell
by AnimalMuppet
by khalic
We could be much more flexible in our approach to things if we would un-ban things. For example after phase 1 trial or based on sufficient observational evidence, things can no longer be banned but have a higher standard for "insurance is now required to cover it".
by mchusma
_Parachute use to prevent death and major trauma related to gravitational challenge: systematic review of randomised controlled trials_
https://pmc.ncbi.nlm.nih.gov/articles/PMC300808/
"Advocates of evidence based medicine have criticised the adoption of interventions evaluated by using only observational data. We think that everyone might benefit if the most radical protagonists of evidence based medicine organised and participated in a double blind, randomised, placebo controlled, crossover trial of the parachute."
by compiler-guy
Nobody reasonable suggests that RCTs must be used for every problem. When the effect size is enormous, or there's obviously no alternative (as in the parachute example), it's silly to suggest the use of an experiment.
On the other hand, if you want to compare some subtle difference between two competing parachute designs, for example, then perhaps an RCT would actually be appropriate. This is much closer to what is actually being measured in real clinical trials.
[1] To be completely fair to the authors, it was intended as a joke, not an argument. The real joke ended up being that people took it seriously.
by timr
This can be more subtly critical than it might seem, in that even if you can manipulate some proxy, often that proxy is insufficient in actually representing the phenomenon of interest, or the conditions under which they actually occur.
I often use the example of videogames and aggression. There were plenty of experimental studies of this but it was always questionable whether lab-induced anger is the same thing as, say, the sort of violence we generally are concerned about societally.
I generally have tried to teach students that experimental designs when done right provide powerful causal evidence of something, but often with limited generalizability; observational designs in contrast provide powerful generalizable evidence of some kind of association, but often with limited certainty about the causal pathways involved.
I've been in a department that was rabidly experimental in its focus and it always seemed sort of short-sighted, because people were idolizing RCTs with proxy manipulations that had questionable generalizability to the real-world phenomena they were trying to model.
Ideally you'd bring both experimental and observational evidence to bear on a question. Your conclusions should be robust to different types of designs.
by derbOac
OP suggests that alternative methods like target trial emulation, propensity scoring and double machine learning can be used to approximate the conditions of an RCT using existing data. In saying so he gives away the tell, which is that RCTs are the standard being aspired to.
Observational data may well be undervalued. But RCTs are still the gold standard.
by CGMthrowaway
Join the discussion
Write your take first — we'll ask for email only when you're ready to publish.
- Hacker News
- The reality that individuals and cultures create can be a dark and confining place. Empiricism is our only window to a universe full of possibility and light. Humanity is like a child, standing on our toes to peer through and wonder.by doginasuit
- They reference RCT without first defining it.by SomeHacker44
- https://en.wikipedia.org/wiki/Randomized_controlled_trial
I noticed that as well. My eyes feverishly scanning the previous paragraph for the definition.
by Vohlenzer - > The increasing availability of large datasets should make this an especially good time to reconsider observational evidence in many fields.
This is not happening.
> I was surprised to find that they usually discard papers based on observational evidence wholesale.
He he...welcome to the real world!
by qsera - RCT is Random Controlled Trial. Definitions are the very basics in writing, check them before you publish.by 1970-01-01
- Where is it defined as "Random Controlled Trial"?by KempyKolibri
- Seth Roberts was arguing this ~20 years ago and would have loved the advent of LLMs...by pinko
- In medicine, observational evidence is actually better and far more ethical than the RCT. (Which simply dooms the terminally ill to fake treatment.) You just need large datasets and an agile culture that's responsive to new input.
Don't forget that RCTs are very far from perfect and issues -- sometimes literally fatal issues -- have later turned up via observational evidence in large cohorts. Vioxx, for instance. Many others.
I believe, without the tiniest shred of doubt, that the only trials drugs need to go through are initial safety/toxicity trials (phases 0/1) and that everything else would be much better left to access+observation.
by A_D_E_P_T - > Which simply dooms the terminally ill to fake treatment.
I wish people would stop saying this. First, controls aren't necessarily "fake treatment", they are often compared to other standard treatments.
Second, the treatment being tested can actually harm the patient more, therefore the people receiving your alleged "fake treatment" can actually come out better off. Which is the "fake treatment" now?
I don't disagree with your final point, but mainly with this increasingly pervasive and wrong framing of RCTs.
by naasking - > In medicine, observational evidence is actually better and far more ethical than the RCT. (Which simply dooms the terminally ill to fake treatment.)
This is just nonsense. First, everyone in a trial is informed of the situation. It's not "unethical" unless you lie about it. If you participate in a trial, you do so knowing that you might not get the experimental drug. It's a selfless, honorable thing to do, and we shouldn't be framing it as some kind of scam.
Second, we don't give terminally ill people "fake treatment" (placebo trials). We give them current standard of care. Giving someone a placebo trial doesn't prove anything that would change clinical practice, because you want to know if the drug works better than what is out there today. Rarely is that standard of care "nothing", and this (bad controls) is actually a primary reason that a lot of drug company trials are rejected by the FDA.
If I didn't see the Wall Street Journal editorial board repeating the same garbage in defense of patent medicines, I'd write you off as simply having a sophomoric understanding of how trials work. I'm convinced that someone is driving this absurd narrative.
by timr - This feels off. In medicine, any evidence can also be blinded by confounding factors that are far easier to miss without adding specific controls. Really, in any field this will be the case.
Should we demand an RCT before we accept evidence? Of course not. At some point you do have to make a choice on things.
And it should be noted that most drugs do have early cutoff criteria if the evidence is strong enough that it is working. It isn't like people are wanting to withhold good treatments from the world. Adding controls and randomizing them, though, has proven to be highly effective at helping progress.
by taeric - Quite thought-provoking, and connecting it to a related field it seems the (relative) success of LLMs and the likes are indications that enough data can at least learn you something without always needing to interfere with the world first(?)by samuell
- Let me restate that: Enough accurate data about the real world can let you learn something about the real world without having to yourself interface with the real world. So, for example, Kepler's Laws were based on Tycho Brahe's observations, not on Kepler's.by AnimalMuppet
- Damn fine article, lovely conclusion, a real pleasure to readby khalic
- Good article. I will only add that I think the problems outlined in the article are exacerbated by the regulatory apparatus. If this were a debate related to truth seeking alone, it would be good. But trials drive banning/unbanning of treatments and medicines, as well as their mandated coverage by insurance.
We could be much more flexible in our approach to things if we would un-ban things. For example after phase 1 trial or based on sufficient observational evidence, things can no longer be banned but have a higher standard for "insurance is now required to cover it".
by mchusma - One classic paper for on this topic:
_Parachute use to prevent death and major trauma related to gravitational challenge: systematic review of randomised controlled trials_
https://pmc.ncbi.nlm.nih.gov/articles/PMC300808/
"Advocates of evidence based medicine have criticised the adoption of interventions evaluated by using only observational data. We think that everyone might benefit if the most radical protagonists of evidence based medicine organised and participated in a double blind, randomised, placebo controlled, crossover trial of the parachute."
by compiler-guy - That's not a "classic". It's just a silly, overwrought straw-man [1] that gets passed around by people who think they're being clever, and/or don't understand the topic with any degree of nuance.
Nobody reasonable suggests that RCTs must be used for every problem. When the effect size is enormous, or there's obviously no alternative (as in the parachute example), it's silly to suggest the use of an experiment.
On the other hand, if you want to compare some subtle difference between two competing parachute designs, for example, then perhaps an RCT would actually be appropriate. This is much closer to what is actually being measured in real clinical trials.
[1] To be completely fair to the authors, it was intended as a joke, not an argument. The real joke ended up being that people took it seriously.
by timr - Experimental designs are critical for obvious reasons but they have a few critical flaws, that mostly all reduce to the fact you can't randomize manipulations with everything. Whether it be due to ethics or practical constraints, you can't conduct a RCT all the time.
This can be more subtly critical than it might seem, in that even if you can manipulate some proxy, often that proxy is insufficient in actually representing the phenomenon of interest, or the conditions under which they actually occur.
I often use the example of videogames and aggression. There were plenty of experimental studies of this but it was always questionable whether lab-induced anger is the same thing as, say, the sort of violence we generally are concerned about societally.
I generally have tried to teach students that experimental designs when done right provide powerful causal evidence of something, but often with limited generalizability; observational designs in contrast provide powerful generalizable evidence of some kind of association, but often with limited certainty about the causal pathways involved.
I've been in a department that was rabidly experimental in its focus and it always seemed sort of short-sighted, because people were idolizing RCTs with proxy manipulations that had questionable generalizability to the real-world phenomena they were trying to model.
Ideally you'd bring both experimental and observational evidence to bear on a question. Your conclusions should be robust to different types of designs.
by derbOac - Yes. Even conceding every point made in this article, RCTs are still the gold standard. The article points out that RCTs are often impractical, expensive or ethically challenging. Well, so is the gold standard of anything.
OP suggests that alternative methods like target trial emulation, propensity scoring and double machine learning can be used to approximate the conditions of an RCT using existing data. In saying so he gives away the tell, which is that RCTs are the standard being aspired to.
Observational data may well be undervalued. But RCTs are still the gold standard.
by CGMthrowaway
Related stories
Halo – open-source, tamper-evident runtime evidence for AI agents
github.com · 35 points · 20 comments
Decoding the obfuscated bash script on a Uniqlo t-shirt
tris.sherliker.net · 1147 points · 189 comments
StreetComplete: Fixing OpenStreetMap, one tiny quest at a time
streetcomplete.app · 761 points · 182 comments
Every new car sold in the European Union must include a driver monitoring camera
allaboutcookies.org · 745 points · 986 comments
Chat Control 1.0 and 2.0 Explained
fightchatcontrol.eu · 645 points · 238 comments
Microsoft fire idTech team at Id software
gamefromscratch.com · 597 points · 533 comments